Market Overview

Shares Of Chimerix Higher By Nearly 6% After Point72 Stake Reveal

The Market In 5 Minutes: G7 Fallout, North Korea Summit, Match Group And More
The Week Ahead In Biotech: Conferences, Clinical Trials And IPOs

Shares of Chimerix Inc (NASDAQ: CMRX), a biopharmaceutical company that develops and commercializes oral antivirals, surged higher by nearly 6 percent early Thursday morning after Point72 Asset Management disclosed a 5.3 percent stake in the company.

Shares of Chimerix plunged more than 80 percent on Monday.

Steve Cohen's Point72 Asset Management reported owning more than 2.45 million shares in the biotechnology company.

CNBC noted that It is unclear if the purchase was made prior to or after Monday's plunge in Chimerix's stock.

Posted-In: biotechnologyBiotech Long Ideas News Hedge Funds Movers Trading Ideas General


Related Articles (CMRX)

View Comments and Join the Discussion!